Author: OurCrowd

[Glilot+ in PR Newswire] Refine Intelligence launches with $13M seed funding to transform anti-money laundering by “Catching the Good Guys”

Nov 14, 2023 |

NEW YORK and TEL AVIV, Israel, Nov. 14, 2023 /PRNewswire/ — Refine Intelligence, the pioneer in Financial Crime Greenflagging, launched today with a $13 million seed funding round led by Glilot Capital Partners and Fin Capital with participation from SYN Ventures, Valley Ventures (the corporate venture capital arm of Valley Bank), and other investors including Ground Up Ventures. Read...

Read More

[DailyPay in PR NewsWire] Infor to offer on-demand pay for employees through new DailyPay partnership

Nov 14, 2023 |

NEW YORK, Nov. 14, 2023 /PRNewswire/ — Infor®, the industry cloud company, today announced a new partnership with DailyPay, the industry leader in on-demand pay, to offer its customers the ability to seamlessly provide employees with easy and quick access to their earned wages. Through this partnership, customers using Infor Workforce Management solutions can provide hourly employees with same-day access to their pay, without disruptions and additional administrative tasks for payroll teams. This will help organizations remain competitive in the ever-evolving employee landscape and support employees in the journey to achieve financial wellness, ultimately increasing employee retention. Read...

Read More

[Cybersixgill in Accesswire] Cybersixgill wins top honors with 2023 CISO Choice Award for Threat Intelligence

Nov 14, 2023 |

TEL AVIV, ISRAEL / ACCESSWIRE / November 14, 2023 / Cybersixgill, the global cyber threat intelligence data provider, announced today that it was named the 2023 CISO Choice Awards winner for Threat Intelligence. Honoring security vendors of all types and sizes, the CISO Choice Awards are the first vendor recognition by a board of judges – leading CISOs across industries – who select the winning solutions and providers based on their real-world experience. Read more...

Read More

[Cordio Medical in EIN Newswires] Cordio Medical presents study validating voice signature AI tool that monitors congestive heart failure

Nov 14, 2023 |

NEW YORK, NEW YORK, UNITED STATES, November 14, 2023 /EINPresswire.com/ — Cordio Medical, developer of the HearO® app, presented the positive results from their clinical study during the American Heart Association’s Scientific Sessions. The research tested and validated the HearO® app, which combines the first smartphone-based mobile speech application and cloud-based computing to detect changes in Speech Measures (SM) indicative of worsening heart failure. Read...

Read More